ZukoBid.
Try it free
Federal contractor profile

Pine Pharmaceuticals LLC

Tonawanda, NY · Not a small business
UEI TCJXKNYD6WL5 · CAGE 7JZE9
Contracts won
15
since Feb 2024 · last Jul 2026
Total value
$1.4M
including options
Buying offices
4
government offices it sold to
Usual competition
1 offer
100% of its wins had one offer

Wins by fiscal year

FY2024
4 · $225K
FY2025
5 · $500K
FY2026
6 · $642K

Who it sells to

National Institutes Of Health Nichd
National Institutes Of Health · 7 wins · $558K
National Institutes Of Health Olao
National Institutes Of Health · 4 wins · $627K
Network Contract Office 23 (36c263)
Veterans Affairs, Department Of · 3 wins · $157K
National Intitutes Of Health Nidcd
National Institutes Of Health · 1 win · $25K

What it wins

Drugs And Biologicals
PSC 6505 · 12 wins · $1.2M
Chemicals
PSC 6810 · 2 wins · $141K
Laboratory Equipment And Supplies
PSC 6640 · 1 win · $25K

Ending in the next 12 months

Contracts that end soon are usually re-bid. These could be openings for a competitor.
Atorvastatin 40 Mg Capsules And Placebo Capsules, Qty 1, 232 Batch.
National Intitutes Of Health Nidcd · ends Feb 2027 · $25K

Recent awards

DateWhatOfficeValueOffers
Jul 2026Niddk: Stable Isotopes Deuterium Oxide (D, 70%), Glycerol (D5 Glycerol), And Glucose (6, 6 Deuterated Glucose)National Institutes Of Health Olao$411K—
Jun 2026Niddk Metabolic IsotopesNational Institutes Of Health Olao$54K—
Apr 20261. 26-003399 - Idiq 75n94024d00003, Send Po To Agentile@Pinepharmaceuticals.Com, Delivery By 6/1/26; Oral Stable Isotope-Deuterium Oxide, Billing In One Lump Sum, Nih Poc Jeannette.Kim@Nih.GovNational Institutes Of Health Olao$39K—
Feb 2026Atorvastatin 40 Mg Capsules And Placebo Capsules, Qty 1, 232 Batch.National Intitutes Of Health Nidcd$25K1
Dec 2025Niddk: Procurement Of Intravenous Stable Isotope Glucose (6, 6 Deuterated Glucose) For Metabolic Research. Nonseverable.National Institutes Of Health Nichd$92K—
Oct 2025503b Compounding PharmaceuticalsNetwork Contract Office 23 (36c263)$20K—
Aug 2025Niddk: Service: Intravenous Stable Isotope Glucose (6, 6 Deuterated Glucose) For Metabolic Research. NonseverableNational Institutes Of Health Nichd$69K—
Jul 2025Niddk: Service: Intravenous Stable Isotope Glucose (D5 Glycerol) For Metabolic Research.National Institutes Of Health Nichd$82K—
Jun 2025Pine Pharmaceuticals, LLC:1270808 [25-001246] The Current Trial Relies On Uniformity Of Drug Formulation, Excipient Composition, Appearance, And Packaging Throughout The Study Period.National Institutes Of Health Olao$122K1
Apr 2025Niddk: Service: Metabolic Isotopes: Non-SeverableNational Institutes Of Health Nichd$159K—
Oct 2024503b Compounding PharmaceuticalsNetwork Contract Office 23 (36c263)$68K—
Sep 2024Niddk: Severable - Acquisition Of Intravenous Stable IsotopesNational Institutes Of Health Nichd$126K1
Sep 2024Niddk Non-Severable Task Order 1 For Metabolic Isotopes.National Institutes Of Health Nichd$15K—
Feb 2024Niddk / Iv Isotope 6, 6 D2glucoseNational Institutes Of Health Nichd$15K1
Feb 2024503b Compounding PharmaceuticalsNetwork Contract Office 23 (36c263)$68K—
Is this your company?

Claim this profile free, and see the open contracts that fit what you win: who else bids, what the government paid last time, and what to bid.

Claim this profile freeCompete with Pine Pharmaceuticals LLC →
From federal contract award records (SAM.gov), base awards over $10K since fiscal year 2024, updated daily. Values include options where reported.
ZukoBid is an independent service, not affiliated with or endorsed by any government agency. Figures come from public records and may contain errors; always check the official listing before you bid. Spotted an error about Pine Pharmaceuticals LLC? Request a correction.